Cyclerion Therapeutics, Inc. Uncategorized Contracts & Agreements
14 Contracts & Agreements
- Amendment to Original Offer Letter Regina Graul (Filed With SEC on August 7, 2024)
- Offer Letter to Regina Graul dated December 1, 2023 (Filed With SEC on March 5, 2024)
- Offer Letter, effective April 1, 2019, by and between Cyclerion Therapeutics, Inc. and Anjeza Gjino (Filed With SEC on March 5, 2024)
- Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 5, 2024)
- Offer Letter, effective April 1, 2019, by and between Cyclerion Therapeutics, Inc. and Cheryl Gault (Filed With SEC on May 4, 2022)
- Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on February 24, 2022)
- Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on February 25, 2021)
- Open Market Sale AgreementSM, dated September 3, 2020, by and between Cyclerion Therapeutics, Inc. and Jefferies LLC (Filed With SEC on September 3, 2020)
- Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 12, 2020)
- Offer Letter, effective April 1, 2019, by and between Cyclerion Therapeutics, Inc. and William Huyett (Filed With SEC on April 2, 2019)
- Offer Letter, effective April 1, 2019, by and between Cyclerion Therapeutics, Inc. and Mark G. Currie, Ph.D (Filed With SEC on April 2, 2019)
- Offer Letter, effective April 1, 2019, by and between Cyclerion Therapeutics, Inc. and Peter M. Hecht, Ph.D (Filed With SEC on April 2, 2019)
- Employee Matters Agreement, dated as of March 30, 2019, by and between Ironwood Pharmaceuticals, Inc. and Cyclerion Therapeutics, Inc (Filed With SEC on April 2, 2019)
- Tax Matters Agreement, dated as of March 30, 2019, by and between Ironwood Pharmaceuticals, Inc. and Cyclerion Therapeutics, Inc (Filed With SEC on April 2, 2019)
